Citation Impact
Citing Papers
Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study
2008 Standout
Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes
2018 StandoutScienceNobel
Recognition of a Ubiquitous Self Antigen by Prostate Cancer-Infiltrating CD8 + T Lymphocytes
2008 StandoutScienceNobel
Long-Lasting Complete Responses in Patients with Metastatic Melanoma after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes and an Attenuated IL2 Regimen
2016
High burden and pervasive positive selection of somatic mutations in normal human skin
2015 StandoutScience
Final Version of 2009 AJCC Melanoma Staging and Classification
2009 Standout
PD-1 + regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer
2019 StandoutNobel
Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial
2007 Standout
Immunotherapy of melanoma
2013
Marked inactivation of O6-alkylguanine-DNA alkyltransferase activity with protracted temozolomide schedules
2003
Public education and cancer of the skin. What do people need to know about melanoma and nonmelanoma skin cancer?
1995
Cancer statistics, 2017
2017 Standout
Cytokines and Vascular Permeability: An In Vitro Study on Human Endothelial Cells in Relation to Tumor Necrosis Factor-α-Primed Peripheral Blood Mononuclear Cells
2006
Granulocyte‐macrophage–colony‐stimulating factor added to a multipeptide vaccine for resected Stage II melanoma
2002
Mutations induced by ultraviolet light
2005
Oncology Meets Immunology: The Cancer-Immunity Cycle
2013 Standout
Generation of Human Melanocytes from Induced Pluripotent Stem Cells
2011 StandoutNobel
UV wavelength-dependent DNA damage and human non-melanoma and melanoma skin cancer
2011
Localized hyperthermic treatment of experimental bone tumors with ferromagnetic ceramics
1993
How useful is SBF in predicting in vivo bone bioactivity?
2006 Standout
31P magnetic resonance spectroscopy as predictor of clinical response in human extremity sarcomas treated by single dose TNF‐α+ melphalan isolated limb perfusion
1995
Tumor necrosis factor, cancer and anticancer therapy
2004
Increased risk of incident HIV during pregnancy in Rakai, Uganda: a prospective study
2005
Epidemiology of melanoma
2000
Clinical applications of TNF-α in cancer
1998
Imaging in the era of molecular oncology
2008 StandoutNature
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Soft-Tissue Sarcomas in Adults
2005 Standout
Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity
2009 Standout
Towards patient‐specific tumor antigen selection for vaccination
2002
Direct isolation, phenotyping and cloning of low-frequency antigen-specific cytotoxic T lymphocytes from peripheral blood
1998
Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells
1999 StandoutNobel
Melanocyte biology and skin pigmentation
2007 Nature
Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer
2017 StandoutNobel
Distinct Sets of Genetic Alterations in Melanoma
2005 Standout
Evidence for the involvement of endotheliai cell integrin αVβ3 in the disruption of the tumor vascuiature induced by TNF and IFN-γ
1998
Malignant Gliomas in Adults
2008 Standout
Current uses of isolated limb perfusion in the clinic and a model system for new strategies
2003
Inflammation and cancer: back to Virchow?
2001 Standout
T Cell Surveillance of Oncogene-Induced Prostate Cancer Is Impeded by T Cell-Derived TGF-β1 Cytokine
2011 StandoutNobel
Current and future developments in the use of temozolomide for the treatment of brain tumours
2001
Cancer immunotherapy comes of age
2011 StandoutNature
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
2005 Standout
Novel methods to monitor antigen-specific cytotoxic T-cell responses in cancer immunotherapy
1998
Interleukin-2: Clinical applications
2002
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
2012 StandoutNatureNobel
Cancer control in women. Update 2003
2003
Childhood sun exposure as a risk factor for melanoma: a systematic review of epidemiologic studies
2001
Cancer-related inflammation
2008 StandoutNature
IFN‐α enhances CD40 ligand‐mediated activation of immature monocyte‐derived dendritic cells
2002
Mutations in GNA11 in Uveal Melanoma
2010 Standout
Maternal mortality: who, when, where, and why
2006 Standout
Labeling of immune cells for in vivo imaging using magnetofluorescent nanoparticles
2006
T-cell responses of vaccinated cancer patients
2003
Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer
2019 StandoutNobel
Cutaneous Squamous-Cell Carcinoma
2001 Standout
Dengue
2007 Standout
Sex Is an Independent Prognostic Indicator for Survival and Relapse/Progression-Free Survival in Metastasized Stage III to IV Melanoma: A Pooled Analysis of Five European Organisation for Research and Treatment of Cancer Randomized Controlled Trials
2013
Detection of self-reactive CD8 + T cells with an anergic phenotype in healthy individuals
2014 StandoutScienceNobel
Antitumor activity of imidazole derivatives: dacarbazine and the new alkylating agent imidazene (Review)
2010
High Frequencies of Naive Melan-a/Mart-1–Specific Cd8+ T Cells in a Large Proportion of Human Histocompatibility Leukocyte Antigen (Hla)-A2 Individuals
1999
Regulatory T Cells and Human Disease
2020 StandoutNobel
Azole-Based Energetic Salts
2011 Standout
TNF-α–based accentuation in cryoinjury—dose, delivery, and response
2007
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010
2013 Standout
PD-L1/B7H-1 Inhibits the Effector Phase of Tumor Rejection by T Cell Receptor (TCR) Transgenic CD8+ T Cells
2004 StandoutNobel
Vaccination with Mage-3a1 Peptide–Pulsed Mature, Monocyte-Derived Dendritic Cells Expands Specific Cytotoxic T Cells and Induces Regression of Some Metastases in Advanced Stage IV Melanoma
1999 StandoutNobel
Integrated NY-ESO-1 antibody and CD8+T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
2011 StandoutNobel
Dendritic-cell maturation alters intracellular signaling networks, enabling differential effects of IFN-α/β on antigen cross-presentation
2006 StandoutNobel
Activation-Induced Cell Death Limits Effector Function of CD4 Tumor-Specific T Cells
2004
Ex Vivo Staining of Metastatic Lymph Nodes by Class I Major Histocompatibility Complex Tetramers Reveals High Numbers of Antigen-experienced Tumor-specific Cytolytic T Lymphocytes
1998
ICOS+Foxp3+TILs in gastric cancer are prognostic markers and effector regulatory T cells associated withHelicobacter pylori
2016 StandoutNobel
Synergism of Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Depletion of Cd25+ Regulatory T Cells in Antitumor Therapy Reveals Alternative Pathways for Suppression of Autoreactive Cytotoxic T Lymphocyte Responses
2001 StandoutNobel
Cytokine Storm
2020 Standout
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
2008 StandoutNobel
Tumor-targeted TNFα stabilizes tumor vessels and enhances active immunotherapy
2012
Effector Function of Human Tumor-Specific CD8 T Cells in Melanoma Lesions: A State of Local Functional Tolerance
2004
Dendritic cells are specialized accessory cells along with TGF-β for the differentiation of Foxp3+ CD4+ regulatory T cells from peripheral Foxp3− precursors
2007 StandoutNobel
Mature Dendritic Cells Prime Functionally Superior Melan-A-Specific CD8+ Lymphocytes as Compared with Nonprofessional APC
2001
HUMAN T CELL RESPONSES AGAINST MELANOMA
2005
Epigenetic conversion of conventional T cells into regulatory T cells by CD28 signal deprivation
2020 StandoutNobel
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+regulatory T cells, evoking antitumor immune responses in humans
2013 StandoutNobel
T cell exclusion, immune privilege, and the tumor microenvironment
2015 StandoutScience
Treg-expressed CTLA-4 depletes CD80/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells
2021 StandoutNobel
Immunotherapy: Bewitched, Bothered, and Bewildered No More
2004 StandoutScienceNobel
Correlation of O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation With Clinical Outcomes in Glioblastoma and Clinical Strategies to Modulate MGMT Activity
2008
The Pten/PI3K pathway governs the homeostasis of Vα14iNKT cells
2006 StandoutNobel
Differential control of human Treg and effector T cells in tumor immunity by Fc-engineered anti–CTLA-4 antibody
2018 StandoutNobel
Interferon in Oncological Practice: Review of Interferon Biology, Clinical Applications, and Toxicities
2001
Works of D. Liénard being referenced
Isolated limb perfusion with tumour necrosis factor-α and melphalan with or without interferon-γ; for the treatment of in-transit melanoma metastases
1999
Prognostic factors for survival and factors associated with long-term remission in patients with advanced melanoma receiving cytokine-based treatments
2002
Melanoma risk and residence in sunny areas
1997
Interferon alfa-2a and interleukin-2 with or without cisplatin in metastatic melanoma: a randomized trial of the European Organization for Research and Treatment of Cancer Melanoma Cooperative Group.
1997
Harly endothelium activation and polymorphonuclear cell invasion precede specific necrosis of human melanoma and sarcoma treated by intravascular high‐dose tumour necrosis factor alpha (rTNFα)
1994
A retrospective comparative study evaluating the results of mild hyperthermic versus controlled normothermic perfusion for recurrent melanoma of the extremities
1995
Cutaneous malignant melanoma and exposure to sunlamps and sunbeds
1991
Final results of the EORTC 18871/DKG 80-1 randomised phase III trial
2003
Cutaneous malignant melanoma and exposure to sunlamps or sunbeds: An eortc multicenter case‐control study in Belgium, France and Germany
1994
Sequential administration of temozolomide and fotemustine: Depletion of O6-alkyl guanine-DNA transferase in blood lymphocytes and in tumours
1999
Rationale for using TNFα and chemotherapy in regional therapy of melanoma
1994
Regional therapy of melanoma
1993
Isolated perfusion of the limb with high-dose tumour necrosis factor-alpha (TNF-alpha), interferon-gamma (IFN-gamma) and melphalan for melanoma stage III. Results of a multi-centre pilot study.
1994
Melanoma-reactive human cytotoxic T lymphocytes derived from skin biopsies of delayed-type hypersensitivity reactions induced by injection of an autologous melanoma cell line.
1997
Expansion and functional maturation of human tumor antigen-specific CD8+ T cells after vaccination with antigenic peptide.
2001
Hyperthermic isolation perfusion of the limbs with cytostatics after surgical excision of sarcomas
1988
Melanoma and use of sunscreens: An EORTC case‐control study in germany, belgium and france
1995
Cytolytic T lymphocyte recognition of the immunodominant HLA-A*0201-restricted Melan-A/MART-1 antigenic peptide in melanoma.
1997
Enhanced generation of specific tumor-reactive CTL in vitro by Melan-A/Mart-1 immunodominant peptide analogs
1997